Sort
15,842 grants matching “pancreatic cancer”
MBQ-167 derivatives as antimetastatic cancer agents.
$89,400Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · R16 · FY2024 · GM
MBQ-167 derivatives as antimetastatic cancer agents.
$89,400Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · R16 · FY2023 · GM
Mechanisms regulating hepatic specification and differentiation in zebrafish
$89,362Chong H Shin · University Of California, San Francisco · K01 · FY2009 · DK
Improving the potency of novel PRMT5 inhibitor with nanocrystal technology to treat pancreatic cancer
$89,349Tao Lu · Indiana University Indianapolis · R03 · FY2025 · CA
Hematopoietic circRNA-mediated intercellular communication
$89,213Roman E Reggiardo · Stanford University · K00 · FY2025 · DK
UNMC Eppley Cancer Center Support Grant
$89,185Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2015 · CA
Core A: Pathology Core
$89,149Anirban Maitra · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA
Porphyromonas gingivalis and Pancreatic Carcinogenesis in Mouse Models
$89,140Caroline A Genco · Tufts University Boston · R03 · FY2019 · CA
Cancer Metabolism Core
$89,060Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2024 · CA
International Symposium on ALPD and Cirrhosis
$89,000Hidekazu Tsukamoto · University Of Southern California · R13 · FY2012 · AA
International Symposium on ALPD and Cirrhosis
$89,000Hidekazu Tsukamoto · University Of Southern California · R13 · FY2011 · AA
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology
$88,913Jonathan P Celli · Massachusetts General Hospital · K99 · FY2011 · CA
Career Enhancement Program
$88,769William E Gillanders · Washington University · P50 · FY2019 · CA
Physiologic Roles of Activin and Myostatin Antagonists
$88,765Alan L Schneyer · University Of Massachusetts Amherst · R01 · FY2010 · DK
Pilot Project Research Project 2
$88,682Ellen Li · State University New York Stony Brook · P20 · FY2016 · CA
CORE--TISSUE RESEARCH AND PATHOLGOGY SERVICES
$88,590Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2006 · CA
Prodrug enzyme therapy of pancreatic cancer mediated by oncolytic HSV vector
$88,500Michael Lanuti · Massachusetts General Hospital · R03 · FY2010 · CA
Lysosomal metabolism as a targetable driver of pancreatic cancer
$88,402Kathleen O'Neill · University Of California, San Francisco · K00 · FY2024 · CA
Gastrointestinal Malignancies
$88,327Charles S Fuchs · Dana-Farber Cancer Inst · P30 · FY2014 · CA
Pancreatic cancer stem cells: PD2-mediated novel mechanistic link and metabolomic alterations
$88,217Saswati Karmakar · Stanford University · K00 · FY2022 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer
$88,115Hui Mao · Emory University · R01 · FY2013 · CA
Developemental Research Program
$88,099Bert Vogelstein · Johns Hopkins University · P50 · FY2011 · CA
mouse phenotyping
$87,923Susan E. Crawford · Northwestern University At Chicago · P30 · FY2011 · CA
Defining the barriers to immune surveillance in solid tumors
$87,804Samarth Hegde · Icahn School Of Medicine At Mount Sinai · K00 · FY2020 · CA
Characterizing Cancer Associated Fibroblast Evolution, Programming, and Fibroblast-Epithelial Cell Crosstalk in Pancreatic Ductal Adenocarcinoma
$87,724Rashmi Janaki Kumar · University Of Michigan At Ann Arbor · F32 · FY2025 · CA